Cited by 56Sex and Gender in HealthcareAcute Myocardial Infarction ResearchCoronary Interventions and Diagnostics

Diagnosis and Treatment of Heart Disease: Are Women Different From Men?

Xhyheri, Borejda, Bugiardini, Raffaele·2010·Progress in Cardiovascular Diseases

Abstract

Key questions concerning strategies for diagnosis, prevention, and treatment of heart disease in women remain unanswered. Thrombolytic therapy has been shown to reduce mortality similarly in men and women. In addition, percutaneous coronary intervention for acute coronary syndromes is as effective in women as in men. However, after hospital discharge, medical treatment carries different benefits in men and women. Aspirin has not been definitively proven to prevent cardiovascular events in women. Men and women respond differently to statins. Men may experience a greater benefit than women from angiotensin-converting enzyme inhibitors. β-Blockers substantially improve survival in women, with possibly a greater benefit than in men. Clopidogrel appears to be equally effective in reducing cardiovascular events in both men and women. Our report will review current knowledge supporting sex differences in the diagnosis and treatment of ischemic heart disease. A clear definition of the state of the science, with recognition of the shortcomings of current data, is necessary to guide future research and move the field forward.

Integrity signals

Registry

Crossref · 10.1016/j.pcad.2010.07.004

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xhyheri, B., & Bugiardini, R.
Affiliations
University of Bologna (IT)
Corresponding author
Bugiardini, Raffaele
Venue
Progress in Cardiovascular Diseases
Publisher
Elsevier BV
Published
2010-11
Volume
53
Issue
3
Pages
227-236
ISSN
0033-0620 (ISSN-L)
OpenAlex
W1978594384
Cited by
56
References
180
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 8
FWCI
0.97
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Cardiovascular Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
Keywords
sex differences, ischemic heart disease, women, thrombolysis, percutaneous coronary intervention, acute coronary syndrome, aspirin, statins, ACE inhibitors, beta-blockers, clopidogrel, cardiovascular disease prevention
MeSH terms
Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Attitude of Health Personnel, Delivery of Health Care, Female, Heart Function Tests, Humans, Health Knowledge, Attitudes, Practice, Male, Platelet Aggregation Inhibitors, Predictive Value of Tests, Sex Factors, Women's Health, Myocardial Ischemia, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Evidence-Based Medicine, Health Status Disparities, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review